44:90:01:01. Definitions. Terms defined in SDCL 34-20G-1 have the same meaning when used in this article. Terms used in this article mean:
(1) “Action level,” the level of a contaminate that triggers action to prohibit a cannabis product from being sold;
(2) “Age-restricted cardholder,” a cardholder or nonresident cardholder who is under eighteen years of age or who is a student as described in § 24:80:02:07;
(3) “Agent identification badge,” a credential provided by an establishment for use by an agent while performing work-related duties;
(4) “Analyte,” a chemical, compound, element, bacteria, yeast, fungus, or toxin that is identified or measured by testing;
(5) “Analytical test,” the use of a single technology to detect the presence or concentration of a single analyte on one or more matrices;
(6) “Authorized transfer,” the distribution of cannabis and cannabis products between medical cannabis establishments that is allowable within inventory tracking system procedures;
(7) “Batch,” a specific quantity of:
(a) Cannabis that is the same strain, grown under the same conditions, and harvested during a specified period of time from a specified cultivation area within a cultivation facility, with the exception of trim; or
(b) Cannabis products that are produced during a specified period of time using the same extraction or manufacturing method, formulation, or recipe;
(8) “Batch identifier,” a unique number or code assigned by an establishment to a quantity of cannabis or cannabis products for testing;
(9) "Cannabinoid," any chemical compound that is an active element of cannabis;
(10) “Cannabis beverage,” a liquid edible cannabis product with a concentration of less than one milligram of delta-9 tetrahydrocannabinol per ounce of liquid;
(11) “Cannabis extract,” the resin extracted from any part of a cannabis plant using a liquid or gaseous solvent other than water;
(12) “Cannabis oil,” an edible cannabis product using a food-safe oil as the primary noncannabis ingredient and with no added flavors, colors, or scents;
(13) “Cannabis testing facility designee,” a person or entity contracted or designated by the testing facility that has documented authorization from the testing facility and has completed the required training for the purposes of sample collection;
(14) “Cannabis waste,” cannabis flower or trim, cannabis seeds, cannabis products, byproducts containing cannabis, or cannabis plants, excluding stalks without trichomes and root balls, that have been designated for destruction;
(15) “Certificate of analysis,” a written report of the results of analytical testing, indicating whether the results comply with this article;
(16) “Chain of custody,” documentation of the handling of cannabis and cannabis products;
(17) “Collective,” two or more cardholders who physically assist each other in the act of cultivating or processing cannabis for medical use, except that the sharing of an enclosed, locked facility for cultivation by two or more cardholders in their own dwelling is not a collective;
(18) “Competitive application,” a medical cannabis establishment application that is scored numerically by the department, in cases where more applicants apply than are allowed by the local government;
(19) “Concentrated cannabis,” cannabis extract or a preparation made by using heat, temperature, or mechanical means to separate cannabinoids from cannabis;
(20) “Confirmation testing,” testing performed by, or at the direction of, the department to determine consistency and accuracy of tests offered by a cannabis testing facility;
(21) "Diversion," the act of selling, gifting, or transferring medical cannabis to a non-cardholder, an unauthorized person, or an unlicensed establishment;
(22) “Equivalent cannabis weight,” the weight, in ounces, that a given quantity of cannabis product counts against the total allowable amount of cannabis under SDCL 34-20G-1(1);
(23) “Exit packaging,” a bag, box, or other container for use in transporting cannabis or cannabis products after purchase at a dispensary;
(24) "Final form," the condition that cannabis or a cannabis product is in immediately prior to transfer to a medical cannabis establishment and immediately prior to presentation for retail sale;
(25) “Flower,” the pistillate reproductive organs of a mature cannabis plant, whether processed or unprocessed, including the flowers and buds of the plant;
(26) “Immature plant,” a nonflowering cannabis plant that measures twelve inches or more from the base of the main plant stalk to the most distant point of the plant's leaf stems or branches;
(27) “Inhalable cannabis product,” a cannabis product that is intended to be consumed by inhalation;
(28) “Inherently hazardous substance,” any solvent or chemical, other than ethanol, with a flash point at or lower than one hundred degrees Fahrenheit;
(29) “Inventory record,” a daily electronic record of all cannabis;
(30) “Inventory tracking system,” an electronic system specified by the department for the purposes of identifying and preventing diversion and protecting patients from unsafe cannabis or cannabis products;
(31) “ISO/IEC 17025 accreditation,” accreditation by the International Accreditation Service, the American Association for Laboratory Accreditation, the American National Standards Institute’s National Accreditation Board, or another laboratory accreditation board that the testing facility meets General Requirements for the Competence of Testing and Calibration Laboratories developed by the International Organization for Standardization and the International Electrotechnical Commission for a particular analyte and technology;
(32) “Low-income,” having a gross monthly household income that is one hundred thirty percent or less of the federal poverty level as defined by § 67:11:01:03;
(33) “Marketing layer,” the outermost layer of a retail sale container predominantly apparent and visible;
(34) “Matrix,” a component or substrate that contains an analyte being tested for;
(35) “Mature plant,” a cannabis plant that has flowered;
(36) “Nationally recognized testing laboratory,” an independent laboratory recognized by the Occupational Health and Safety Administration pursuant to 29 C.F.R. § 1910.7, in effect on February 18, 2020;
(37) “Nonusable,” unfit for sale or, except for the purposes of remediation, transfer;
(38) “Remediation,” the further processing of a batch of cannabis or cannabis products that has failed testing, using a process approved by the department to address the reasons for the failure;
(39) “Representative sample,” the amount of cannabis and cannabinoids within the product being consistent and reasonably equally dispersed throughout the product or each portion of the product;
(40) “Sample identifier,” a unique number or code assigned to a sample to be tested by a testing facility, either by the establishment submitting the sample or an agent of the testing facility;
(41) “Seedling,” a nonflowering cannabis plant or rooted cutting that measures less than twelve inches from the base of the main plant stalk to the most distant point of the plant's leaf stems or branches;
(42) “Testing sample record,” a daily electronic record maintained by an establishment of batch identifiers, sample identifiers, and associated information;
(43) "Tetrahydrocannabinol," the primary psychoactive cannabinoid found in the Cannabis sativa plant, also known as delta-9;
(44) “Tincture,” a liquid edible cannabis product with a concentration of greater than one milligram of tetrahydrocannabinol per ounce of liquid in the form of ethanol, propylene glycol, glycerin, or food safe oil;
(45) “Topical cannabis product,” a nonedible cannabis product that is intended to be applied externally to the skin;
(46) "Total tetrahydrocannabinol," the percentage of cannabis or a cannabis product calculated as the percentage of tetrahydrocannabinolic acid times 0.877 plus the percentage of tetrahydrocannabinol;
(47) “Transaction record,” a daily electronic record created and maintained by a dispensary to track transactions with patients;
(48) “Transfer record,” a daily electronic record of any acquisition of seeds, seedlings, plants, cannabis, or cannabis products and any transfer of cannabis or cannabis products to another medical cannabis establishment;
(49) “Trim,” trichome-containing leaves of the cannabis plant that have been intentionally removed during cultivation; and
(50) “Vaporizer product,” an inhalable cannabis pen or cartridge containing only concentrated cannabis that is heated below the point of combustion.
Source: 48 SDR 40, effective October 5, 2021; 49 SDR 9, effective August 8, 2022; 50 SDR 62, effective November 27, 2023.
General Authority: SDCL 34-20G-72.
Law Implemented: SDCL 34-20G-1, 34-20G-72.
Reference: International Organization for Standardization & International Electrotechnical Commission. (2018). ISO/IEC 17025:2017: General Requirements for the Competence of Testing and Calibration Laboratories. https://www.iso.org/standard/66912.html. Cost: $138.
Cross-Reference: Federal poverty level, § 67:11:01:03.
